It is a pharma private limited company based in Pune, Maharashtra, India, established in 2022.
2022 | Pune, Maharashtra, India | ActiveSkyland Pharmaceutical Private Limited, a active private limited company, was established on 20 January 2022 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24290PN2022PTC207867. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.71 M.
It upholds a compliant status. Its leadership includes Rameshwar Haribhau Chavan (Additional Director), Ganesh Dadasaheb Phalke (Additional Director), Ram Kisan Dhumak (Additional Director). Past directors included Sandip Bhausaheb Bangal, Prasad Pandurang Bajaj. It is based at Sr No 219/2, Flat No. B/311, Swagat Hos.Soc., Charholi, Kh. Ta.Khed, Pune, Maharashtra, 412105.
U24290PN2022PTC207867
207867
20 January 2022
₹3.00 M
₹1.71 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Skyland Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rameshwar Haribhau Chavan | Additional Director | 11 Apr 2023 | Current |
| Ganesh Dadasaheb Phalke | Additional Director | 11 Apr 2023 | Current |
| Ram Kisan Dhumak | Additional Director | 11 Apr 2023 | Current |
| Ganesh Hanuman Kakade | Additional Director | 11 Apr 2023 | Current |
| Ramnath Dagduji Tikande | Additional Director | 11 Apr 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 May 2023 | Past |
| Pramod Abcsdd | Director | 15 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Skyland Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Skyland Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Skyland Pharmaceutical has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skyland Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skyland Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rameshwar Haribhau Chavan was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Ganesh Dadasaheb Phalke was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Progress on Ram Kisan Dhumak was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was documented.
The activity Ganesh Hanuman Kakade was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was completed.
Progress on Ramnath Dagduji Tikande was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was documented.
Progress on Skyland Pharmaceutical Private Limited was registered on 20 Jan 2022 with Roc Pune & aged 3 years 10 months as per MCA records. was documented.
The CIN of Skyland Pharmaceutical Private Limited is U24290PN2022PTC207867.
Skyland Pharmaceutical Private Limited is headquartered at Sr No 219/2, Flat No. B/311, Swagat Hos.Soc., Charholi, Kh. Ta.Khed, Pune, Maharashtra, 412105.
Skyland Pharmaceutical Private Limited was incorporated on 20 January 2022.
The current directors of Skyland Pharmaceutical Private Limited are
The primary industry of Skyland Pharmaceutical Private Limited is Pharma.
Skyland Pharmaceutical Private Limited is unlisted.
The authorized capital of Skyland Pharmaceutical Private Limited is ₹3.00 M, and the paid-up capital is ₹1.71 M.
The compliance status of Skyland Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX